Catch up on the 9 FDA drug approvals most relevant to primary care, including new options for HIV-1 infection, narcolepsy, diabetes, pain management, and more.
News|Slideshows|June 24, 2020
Issues in Insulin Management: 3 Cases of Type 2 Diabetes
Author(s)Sudipa Sarkar, MD
Three patients with type 2 diabetes in different stages of life and disease all require insulin management for A1c control.
Advertisement
Three patients present to you for type 2 diabetes follow-up care in different stages of disease progression and at different levels of treatment with insulin. Should regimens be changed? Should insulin be swapped out? What is the 2020
Advertisement
Related to this article
The FDA has approved insulin efsitora alfa-gobe (Onswik) for adults with type 2 diabetes.
New research links type 2 diabetes and genetic risk to MASLD cirrhosis before 50, warning age-based fibrosis scores can miss severe disease.
Finerenone wins FDA clearance for type 1 diabetes–related CKD, lowering albuminuria in FINE-ONE and opening a long-awaited treatment path.
The US FDA cleared a novel insulin patch pump that can be used for up to 3 days with an additional 12-hour grace period in persons with diabetes.
Tirzepatide gained an FDA cardiovascular indication after SURPASS-CVOT showed noninferiority to dulaglutide in high-risk adults.
FDA authorized Abbott’s Libre Duo 10 Day system, the first wearable device to continuously monitor both glucose and ketones.
FDA has granted IDE approval for the STROKE-REWIRE pivotal trial evaluating NeuWire Medical's neurostimulation device for chronic ischemic stroke recovery.
Advertisement
Advertisement
Trending on Patient Care Online
1
9 Drugs Approved for Primary Care: Q3 2026
2
Immunizing Against Pain and Fear: Rethinking the Vaccination Experience
3
Switch to Oral Semaglutide Linked to 4.1% Weight Loss at 3 Months in New Study
4
HIV Testing Before and During PrEP: Getting It Right
5